Exercise on semaglutide: what the evidence actually shows

What the STEP 1 trial tells us about exercise and semaglutide

The STEP 1 trial, published in the New England Journal of Medicine, is the cornerstone evidence for semaglutide 2.4mg in weight management. The 68-week trial enrolled adults with obesity or overweight and a weight-related condition, and all participants received lifestyle counselling, including guidance on physical activity, alongside either semaglutide or placebo. The semaglutide group achieved an average body-weight reduction of around 15%. The trial design matters here: the weight loss figures people quote were achieved with lifestyle support, not in spite of it. Semaglutide reduces appetite and slows gastric emptying, which helps people eat less, but it does not independently tell the body to burn stored fat. Physical activity adds a second lever, one that also protects lean tissue.

Preserving muscle during weight loss is more significant than it might sound. When people lose weight rapidly without exercising, a proportion of that loss is lean mass, not just fat. Less muscle means a lower resting metabolic rate, which can make maintaining a lower weight harder over time. Resistance or strength-based activity, even bodyweight exercises at home, can help offset this. It is also why our clinical team will often ask about your activity habits as part of your consultation, not to set targets, but to build a picture of what support you might need.

Semaglutide side effects and timing your workouts

The most frequently reported side effects of semaglutide are gastrointestinal: nausea, bloating, indigestion, and sometimes vomiting or diarrhoea. These tend to be most noticeable after starting or after a dose increase, and they usually ease within the first week or two at each new dose level. For exercise, this has a practical implication. High-intensity training or anything that involves a lot of abdominal compression can feel unpleasant if nausea is present. Many people find lower-impact activities, walking, swimming, cycling, or yoga, more comfortable during those early weeks, saving harder sessions for when things have settled.

Hydration matters too. Semaglutide can reduce how much you drink as well as how much you eat, and exercise increases fluid loss. Drinking steadily throughout the day, not just at mealtimes, becomes worth a bit more attention on treatment. If you keep your pen in the fridge door at home, a useful habit is pairing your weekly injection day with a check-in on how you have been managing both food and fluids that week. Detailed side-effect information is available on the NHS semaglutide medicines page.

For anyone thinking about how to structure activity specifically around their Wegovy treatment, our guide on how Wegovy and exercise work together works through this in more practical detail.

What type of exercise works best alongside semaglutide treatment?

There is no single answer, and anyone who says otherwise is overstating the evidence. What the data support is a combination: aerobic activity for cardiovascular and metabolic benefit, and resistance training to protect lean mass. The balance between those depends on your current fitness, any joint or health considerations, and what you will actually keep doing. A plan you abandon after three weeks because it is too ambitious achieves less than moderate activity sustained consistently.

UK physical activity guidelines recommend 150 minutes of moderate-intensity activity each week, spread across several sessions, alongside muscle-strengthening on two or more days. For people starting from a low baseline, that goal is a horizon rather than a starting point. Brisk walking counts. Housework can count. The point is progressive movement, not perfection. Our page on what kinds of activity tend to work well on Wegovy explores this further, including how to adapt if the usual GI side effects are making some types of movement uncomfortable.

If you want more structure around building activity into your routine, our Wegovy exercise plan guide sets out a practical framework you can work through at your own pace. If you are curious about whether regular activity is strictly required for semaglutide to work, or whether skipping it changes outcomes significantly, our page on whether you need to exercise on Wegovy addresses that directly, and our separate guide on whether you have to exercise on Wegovy looks at the question from a slightly different angle, including what the evidence says about outcomes for people who do less activity.

What this means for anyone considering semaglutide treatment

Semaglutide is a prescription-only medicine, and the UK licence for Wegovy (semaglutide 2.4mg and now also the 7.2mg dose) specifies use alongside a reduced-calorie diet and increased physical activity. That is not a footnote; it is part of the treatment framework the medicine was evaluated within. NICE's recommendation for semaglutide, outlined in NICE technology appraisal TA875, similarly places it within a managed programme that includes lifestyle support.

For people exploring whether semaglutide treatment might be right for them, the consultation step is where these questions belong. A prescriber can look at your health history, any conditions or medicines that affect what is appropriate, and help you think about realistic activity goals as part of the plan, not as an afterthought. At nume, a GPhC-registered prescriber reads your consultation personally on the same day, not a piece of software. You can learn more about what semaglutide treatment involves on our semaglutide overview page, or find out about the broader range of weight-loss treatments we offer. When you are ready to take the next step, speak to our prescribers through a free consultation.